| Literature DB >> 31513619 |
Caroline Morbach1,2, Bettina N Walter1, Margret Breunig1,2, Dan Liu1,2, Theresa Tiffe1,3, Martin Wagner1,3, Götz Gelbrich3,4, Peter U Heuschmann1,3,4, Stefan Störk1,2.
Abstract
AIMS: We aimed to provide reference values for speckle-tracking derived systolic and diastolic myocardial deformation markers, and to determine their relation with age, sex, and cardiovascular risk factors. METHODS ANDEntities:
Mesh:
Year: 2019 PMID: 31513619 PMCID: PMC6742365 DOI: 10.1371/journal.pone.0221888
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical and echocardiographic characteristics of study participants, and subgroups without and with cardiovascular risk factors.
| Total | Healthy | With cardiovascular risk factor | P | |
|---|---|---|---|---|
| n | 1818 | 542 | 1276 | |
| Age [years], mean (SD) | 54 (12) | 49 (11) | 56 (12) | <0.001 |
| Female sex, n (%) | 937 (52) | 313 (58) | 624 (49) | <0.001 |
| BMI [kg/m2], mean (SD) | 26 (9) | 24 (3) | 28 (11) | <0.001 |
| Systolic BP [mmHg], mean (SD) | 124 (15) | 118 (11) | 127 (16) | <0.001 |
| Diastolic BP [mmHg], mean (SD) | 75 (10) | 72 (9) | 76 10) | <0.001 |
| Heart rate [min-1], mean (SD) | 62 (13) | 62 (9) | 63 (15) | 0.929 |
| Total cholesterol [mg/dl], mean (SD) | 20 (38) | 202 (35) | 208 (39) | 0.001 |
| HDL cholesterol [mg/dl], mean (SD) | 64 (19) | 68 (18) | 62 (19) | <0.001 |
| LDL cholesterol [mg/dl], mean (SD) | 121 (35) | 117 (31) | 123 (36) | <0.001 |
| Triglycerides [mg/dl], mean (SD) | 108 (81) | 84 (43) | 119 (91) | <0.001 |
| HbA1c [%], mean (SD) | 5.5 (0.6) | 5.3 (0.3) | 5.6 (0.6) | <0.001 |
| N | 1752 | 520 | 1232 | |
| mean (SD) | 53 (11) | 53 (10) | 53 (11) | 0.387 |
| N | 1218 | 323 | 895 | |
| mean (SD) | -19.1 (2.4) | -19.7 (2.2) | -18.9 (2.5) | <0.001 |
| N | 1506 | 411 | 1095 | |
| mean (SD) | -0.95 (0.15) | -0.98 (0.14) | -0.94 (0.15) | <0.001 |
| N | 1506 | 411 | 1095 | |
| mean (SD) | 1.19 (0.37) | 1.32 (0.36) | 1.13 (0.36) | <0.001 |
| N | 1500 | 408 | 1092 | |
| mean (SD) | 0.80 (0.21) | 0.82 (0.21) | 0.76 (0.19) | <0.001 |
| N | 1752 | 520 | 1232 | |
| mean (SD) | 48.4 (4.7) | 47.6 (4.5) | 48.8 (4.8) | <0.001 |
| N | 1711 | 482 | 1229 | |
| mean (SD) | 8.7 (1.3) | 8.1 (1.1) | 8.9 (1.3) | <0.001 |
| N | 1710 | 482 | 1228 | |
| mean (SD) | 8.2 (1.2) | 7.5 (1.1) | 8.4 (1.2) | <0.001 |
| N | 1689 | 499 | 1190 | |
| mean (SD) | 16.8 (3.1) | 15.7 (2.7) | 17.2 (3.1) | <0.001 |
| N | 1729 | 517 | 1212 | |
| mean (SD) | 60.4 (4.5) | 61.0 (4.1) | 60.1 (4.6) | <0.001 |
| N | 1720 | 516 | 1204 | |
| mean (SD) | 0.11 (0.03) | 0.12 (0.03) | 0.10 (0.03) | <0.001 |
| N | 1714 | 515 | 1199 | |
| mean (SD) | 7.0 (2.3) | 6.3 (1.7) | 7.3 (2.5) | <0.001 |
Values are given as mean ± standard deviation. P values refer to the comparison of healthy individuals versus individuals with cardiovascular risk factors.
BP = blood pressure, HDL = high density lipoprotein, LDL = low density lipoprotein, HbA1c = hemoglobin A1c, GL-PSS = global longitudinal peak systolic strain, SR = strain rate, LVEDD = left ventricular end-diastolic diameter, IVSd = interventricular septum end-diastolic, LVPWd = left ventricular posterior wall end-diastolic, LA = left atrium, LVEF = left ventricular ejection fraction, e´ = PW-Doppler derived early diastolic myocardial lengthening velocity, E = early mitral inflow velocity
Fig 1Number of individuals in each sub-sample in whom strain parameters could be derived.
GL-PSS = global longitudinal peak systolic strain, GL-SSR = global longitudinal systolic strain rate, GL-EDSR = global longitudinal early diastolic strain rate, and GL-LDSR = global longitudinal late diastolic strain rate.
Fig 2Combined averaged a) global longitudinal peak systolic strain (GL-PSS, n = 323), b) systolic strain rate (GL-SSR, n = 410), c) early diastolic strain rate (GL-EDSR, n = 410), and d) late diastolic strain rate (GL-LDSR, n = 407) according to age and sex in individuals in sinus rhythm free from cardiovascular risk factors and cardiovascular disease (mean age 49±11 years, 55% females).
Speckle tracking derived markers of left ventricular myocardial deformation in male participants by age group.
| Age group (years) | 30–39 | 40–49 | 50–59 | 60–79 | P |
|---|---|---|---|---|---|
| | 25 | 53 | 38 | 30 | |
| | -17.8 (1.7) | -18.9 (2.0) | -19.0 (2.3) | -18.8 (2.5) | 0.160 |
| | -21.3; -14.4 | -22.9; -14.9 | -23.6; -14.4 | -23.8; -13.8 | |
| | 34 | 70 | 39 | 40 | |
| | -0.93 (0.10) | -0.95 (0.13) | -0.95 (0.18) | -0.93 (0.14) | 0.691 |
| | -1.13; -0.73 | -1.21; -0.69 | -1.31; -0.59 | -1.21; -0.65 | |
| | 34 | 70 | 39 | 40 | |
| | 1.30 (0.26) | 1.23 (0.24) | 1.16 (0.28) | 0.95 (0.27) | <0.001 |
| | 0.78; 1.82 | 0.75; 1.71 | 0.60; 1.72 | 0.41; 1.49 | |
| | 34 | 69 | 39 | 40 | |
| | 0.62 (0.13) | 0.75 (0.18) | 0.82 (0.17) | 0.87 (0.21) | <0.001* |
| | 0.36; 0.88 | 0.39; 1.11 | 0.48; 1.16 | 0.45; 1.29 |
Values are given as mean ± standard deviation. P values refer to the comparison of age groups using ANCOVA or *Welch´s test, depending on equality of variance in Levene´s test. To increase statistical power, the two top decades were combined.
SD = standard deviation, CI = confidence interval, GL-PSS = global longitudinal peak systolic strain
Speckle tracking derived markers of left ventricular myocardial deformation in female participants by age group.
| Age group (years) | 30–39 | 40–49 | 50–59 | 60–79 | P |
|---|---|---|---|---|---|
| | 28 | 73 | 42 | 34 | |
| | -20.7 (2.2) | -20.5 (1.8) | -20.7 (1.6) | -19.6 (2.4) | 0.120* |
| | -25.1; -16.3 | -24.1; -16.9 | -24.1; -17.3 | -24.4; -14.8 | |
| | 38 | 97 | 53 | 40 | |
| | -1.06 (0.15) | -1.02 (0.13) | -1.02 (0.10) | -0.98 (0.15) | 0.174* |
| | -1.36; -0.76 | -1.28; -0.76 | -1.22; -0.82 | -1.28; -0.68 | |
| | 38 | 97 | 53 | 40 | |
| | 1.69 (0.35) | 1.52 (0.35) | 1.35 (0.27) | 1.15 (0.36) | <0.001 |
| | 0.99; 2.39 | 0.82; 2.22 | 0.81; 1.89 | 0.43; 1.87 | |
| | 37 | 97 | 52 | 40 | |
| | 0.65 (0.15) | 0.69 (0.15) | 0.82 (0.15) | 0.94 (0.16) | <0.001 |
| | 0.35; 0.95 | 0.39; 0.99 | 0.52; 1.12 | 0.62; 1.26 |
Values are given as mean ± standard deviation. P values refer to the comparison of age groups using ANCOVA or *Welch´s test, depending on equality of variance in Levene´s test. To increase statistical power, the two top decades were combined. SD = standard deviation, CI = confidence interval, GL-PSS = global longitudinal peak systolic strain
Impact of cardiovascular risk factors on myocardial deformation in the total cohort and according to sex.
| CV risk factor | Impact of CV risk factor | Effect size women vs. men | |||||
|---|---|---|---|---|---|---|---|
| Obesity | +0.7% | <0.001 | +0.9% | <0.01 | <0.01 | 0.69 | |
| Hypertension | +0.3% | ns | +0.7% | <0.01 | ns | 0.004 | |
| Dyslipidemia | +0.3% | <0.001 | +1.2% | <0.001 | ns | 0.03 | |
| Obesity | +0.04 s-1 | <0.001 | +0.06 s-1
| <0.001 | ns | 0.047 | |
| Hypertension | +0.03 s-1 | <0.01 | +0.06 s-1
| <0.001 | ns | 0.02 | |
| Dyslipidemia | +0.03 s-1 | <0.05 | +0.05 s-1
| <0.01 | ns | 0.07 | |
| Obesity | -0.12 s-1 | <0.001 | -0.14 s-1
| <0.001 | <0.001 | 0.72 | |
| Hypertension | -0.72 s-1 | <0.001 | -0.24 s-1
| <0.001 | <0.001 | <0.001 | |
| Dyslipidemia | -0.12 s-1 | <0.001 | -0.19 s-1
| <0.001 | ns | 0.001 | |
| Hypertension | +0.09 s-1 | <0.001 | +0.11 s-1
| <0.001 | <0.001 | 0.02 |
The impact of a CV risk factor on a specific strain marker is expressed as absolute change for the total sample and per sex group. Interaction effects computed from general linear models (see Methods).
CV = cardiovascular, vs. = versus, GL-PSS = global longitudinal peak systolic strain (n = 1218), GL-SSR = global longitudinal systolic strain rate (n = 1506), GL-EDSR = global longitudinal early diastolic strain rate (n = 1506), GL-LDSR = global longitudinal late diastolic strain rate (n = 1500), ns = not significant; Hypertension = blood pressure ≥140/90 mmHg or antihypertensive pharmacotherapy, dyslipidemia = low density lipoprotein ≥190 mg/dl or lipid-lowering pharmacotherapy, obesity = body mass index >30 kg/m2.